NDC 68462-467
rizatriptan benzoate 5 mg tablet, orally disintegrating
On the label: Glenmark Pharmaceuticals Inc., USA.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Goa, India | Makes it and tests it | Problems found, fixed voluntarilyJun 30, 2026 · 7 inspections, 1 with FDA action |
Recalls
- May 13, 2024 · Class II · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.
Lots: Lot#: 19224857; Exp. 11/2024 Lot#: 19232493; Exp. 6/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Rizatriptan: every company that makes it
- Form
- tablet, orally disintegrating, oral
- Strength
- 5 mg
- Approval
- ANDA ANDA201914
- On the market since
- Jul 1, 2013
- Package NDCs
68462-467-0668462-467-4668462-467-74- Official label
- DailyMed (National Library of Medicine), updated Oct 9, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?